Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Red blood cell (RBC) transfusions have been shown to exert immunosuppressive effects in different diseases. In consequence, RBC transfusions might also negatively influence the response to immunotherapeutic treatment approaches. To address how RBC transfusions impact response rates of antitumor immu...
Main Authors: | Rebekka Mispelbaum, Sandra Tessa Hattenhauer, Peter Brossart, Annkristin Heine |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.976011/full |
Similar Items
-
Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients
by: Rebekka Mispelbaum, et al.
Published: (2022-11-01) -
Neonatal red blood cell transfusion practices in Switzerland: national survey and review of international recommendations
by: Romaine Arlettaz Mieth, et al.
Published: (2020-01-01) -
Transfusions of packed red blood cells in the pathology of newborn
by: Paulina Trojanowska, et al.
Published: (2019-09-01) -
Transfusions of packed red blood cells in the pathology of newborn
by: Paulina Trojanowska, et al.
Published: (2019-09-01) -
Red Blood Cell Alloimmunization in Multi - transfused Patients: A Bicentric Study in India
by: Amit Agrawal, et al.
Published: (2016-01-01)